title: Comment on: Fraser et al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 2012;35:1095-1097.
authors.forename: Dan
authors.initials: D
authors.lastname: Ziegler
authors.forename: Solomon
authors.initials: S
authors.lastname: Tesfaye
authors.forename: Peter
authors.initials: P
authors.lastname: Kempler
mesh_terms: D015415:Biomarkers / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D010525:Peripheral Nerves / Q000187:drug effects*; D013831:Thiamine / Q000031:analogs & derivatives*
chemical_list: D015415:Biomarkers; D013831:Thiamine